Mw. Maccumber et al., TISSUE-PLASMINOGEN ACTIVATOR FOR PRESERVING INFERIOR PERIPHERAL IRIDECTOMY PATENCY IN EYES WITH SILICONE OIL, Ophthalmology, 103(2), 1996, pp. 269-273
Purpose: An inferior peripheral iridectomy (IPI) was used to prevent f
orward migration of silicone oil in vitrectomized eyes; however, in ap
proximately one third of eyes, the IPI closed spontaneously. Occlusion
of the IPI by fibrin is believed to be an early event in permanent IP
I closure by scar tissue. The authors determined whether intraocular t
issue plasminogen activator (tPA) would restore and maintain IPI paten
cy in eyes that had early occlusion of the IPI by fibrin. Methods: Bet
ween November 1993 and January 1995, 12 patients who underwent vitrect
omy with silicone tamponade and IPI for complicated retinal detachment
received an anterior chamber injection of tPA (6.25 or 12.5 mu g) for
occlusion of the IPI by fibrin. Results: All 12 patients had lysis of
fibrin and maintained a patent IPI at the last follow-up (124 +/- 95
days). One patient required multiple tPA injections for recurrent fibr
in formation. In another patient, a small hyphema developed after the
tPA injection, which did not occlude the IPI. When compared with the n
atural course in a very similar group of patients previously reported,
tPA had a statistically significant beneficial effect in the maintena
nce of IPI patency (P = 0.040). Conclusions: Intraocular tPA can be sa
fely used to lyse postoperative fibrin occluding the IPI in eyes with
silicone oil tamponade. Early lysis of this fibrin maintains IPI paten
cy.